Pre-diabetes as a Critical Stage for Risk of Dementia and Stroke: Evidence from the UK Biobank and Mendelian Randomization

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background and Aims

Type 2 diabetes (T2D) is a recognized risk factor for dementia and stroke, but whether risks begin during pre-diabetes remains unclear. We aimed to determine the risks of these neurological conditions with pre-diabetes and the glycemic thresholds at which risks emerge.

Methods

We studied 432,285 adults (mean age, 57 years; 55% women) from the UK Biobank who were free from prior dementia or stroke at baseline. Glycemic status (normoglycemia, pre-diabetes, T2D) was defined by HbA1c. Incident dementia, stroke, and MRI-derived brain markers, including brain volumes and white matter hyperintensity volumes, were assessed for these conditions. HbA1c was modeled continuously to assess non-linear effects. Outcomes were estimated using competing risks and linear regression models, adjusted for demographic, lifestyle, and clinical factors. Two-sample Mendelian randomization (MR) was used to test causality.

Results

During a median 13.7 years of follow-up, pre-diabetes was associated with higher risks of Alzheimer’s disease (HR:1.30; 95% CI: 1.16-1.45), vascular dementia (HR:1.50; 95% CI: 1.28-1.7), and all-cause stroke (HR:1.24; 95% CI: 1.16-1.33), independent of other vascular risk factors. On brain MRI (N=3,723), total and grey matter volumes and hippocampal volumes were smaller, and white matter hyperintensity volume was larger in pre-diabetes. Spline models indicated that adverse outcomes emerged at HbA1c levels around 40-45 mmol/mol, below the diabetes threshold. Risks were further elevated in T2D. MR analyses supported causal effects of glycemia on Alzheimer’s disease, stroke, and hippocampal atrophy.

Conclusion

Pre-diabetes is not a benign state: even modest HbA1c elevations are linked to dementia, stroke, and brain structural decline. These risks emerge below current diagnostic glycemic thresholds, underscoring pre-diabetes as a critical stage for early intervention to preserve brain health.

Lay Summary

This study shows that even before diabetes develops, higher HbA1c levels are linked to increased risks of dementia, stroke, and brain damage.

  • People with pre-diabetes had a higher chance of developing Alzheimer’s disease, other forms of dementia, such as vascular dementia, and stroke. Brain scans also showed earlier signs of shrinkage and damage.

  • These risks appeared even before blood sugar reached the level used to diagnose diabetes, highlighting the importance of early monitoring and healthy lifestyle changes to reduce the risk of dementia and stroke.

Article activity feed